Conmed Pharmaceutical & Bio-Medical Corporation
Conmed Pharmaceutical & Bio-Medical Corporation
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2025-09-19 | NCT07182422 |